Cost of acute myocardial infarction in Hong Kong

Disease Management and Health Outcomes

Volumn 13, Issue 4, 2005, Pages 281-285

  Lee, Vivian W Y ^a,c   Chan, Wai Kwong ^b   Lam, Nelson L C ^a   Lee, Kenneth K C ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIFIBRINOLYTIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ACUTE HEART INFARCTION; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC TEST; DRUG COST; HEALTH CARE COST; HONG KONG; HOSPITALIZATION; HUMAN; OUTPATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; Q WAVE;

EID: 23744515292     PISSN: 11738790     EISSN: 11738790     Source Type: Journal    
DOI: 10.2165/00115677-200513040-00006     Document Type: Article

References (19)

1. Mehta RH, Montoye CK, Gallogly MBA, et al., for the GAP Steering Committee of the American College of Cardiology. Improving quality care for acute myocardial infarction: the guidelines applied in practice (GAP) initiative. JAMA 2002; 287 (10): 1269-76
2. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarc-tion). J Am Coll Cardiol 1999; 34: 890-911
3. Madsen JK. Acute myocardial infarction. Circulation 1997; 96: 748-55
4. Russell MW, Huse DM, Drown SMA, et al. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998; 81 (9): 1110-5
5. Woo J, Cockram C. Cost estimates for chronic diseases. Dis Manage Health Outcomes 2000; 8 (1): 29-41
6. List of charges. Hong Kong Government Gazette, Special Supplement No. 4 (13), 2003
7. The Hong Kong Hospital Authority. International comparison of population and health statistics [online]. Available from URL: http://www.ha.org.hk/hesd/ nsapi/drivernsapi20.so/?Mlval=ha_visitor_index&intro=ha%5fview%5ftemplate% 26group%3dHFA%26Area%3dPHS [Accessed 2003 Oct 21]
8. Muramatsu N, Liang J. Hospital length of stay in the United States and Japan: a case study of myocardial infarction patients. Int J Health Serv 1999; 29 (1): 189-209
9. Matsui K, Polanczyk CA, Gaspoz JM, et al. Management of patients with acute myocardial infarction at five academic medical centers: clinical characteristics, resource utilization, and outcome. J Investig Med 1999; 47 (3): 134-40
10. Gatin A, Budlot A, Bismuth MJ, et al. Medico-economic impact of the Program of Medicalization of the information system on hospital stay for myocardial infarction: influence of the quality of data collection and hospitalization length. Ann Cardiol Angeiol (Paris) 2001; 50 (4): 189-96
11. Newby KL, Eisenstein EL, Califf RM, et al. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med 2000; 342 (11): 749-55
12. Koenig C, Stevermer J. Is a 3-day hospitalization cost-effective for patients after uncomplicated acute myocardial infarction (AMI)? J Fam Pract 2000; 49 (6): 574
13. Antman EM, Kuntz KM. The length of the hospital stay after myocardial infarction. N Engl J Med 2000; 342 (11): 808-10
14. Schultz MA, van Servellen G, Chang BL, et al. The relationship of hospital structural and financial characteristics to mortality and length of stay in acute myocardial infarction patients. Outcomes Manag Nurs Pract 1998; 2 (3): 130-6
15. Zethraeus N, Molin T, Henriksson P, et al. Costs of coronary heart disease and stroke: the case of Sweden. J Intern Med 1999; 246 (2): 151-9
16. O'Brien JA, Caro I, Getsios D, et al. Diabetes in Canada: direct medical costs of major macrovascular complications. Value Health 2001; 4 (3): 258-65
17. Laffel GL, Fineberg HV, Braunwald E. A cost-effectiveness model for coronary thrombolysis/reperfusion therapy. J Am Coll Cardiol 1987; 10: 79B-90B
18. Smith TL, Melfi CA, Kesterson JA, et al. Direct medical charges associated with myocardial infarction in patients with and without diabetes. Med Care 1999; 37 (4): AS4-AS11
19. Schellevis F, van der Velden J, van der Lisdonk E, et al. Comorbidity of chronic diseases in general practice. J Clin Epidemiol 1993; 46: 469-73